Literature DB >> 9566833

Hemodynamic changes in patients developing effective hypovolemia after total paracentesis.

M C Vila1, R Solà, L Molina, M Andreu, S Coll, J Gana, J Marquez, J Palá, F Bory, S Pons, L Szescielinski, W Jimenez.   

Abstract

BACKGROUND/AIMS: In many centers paracentesis is considered the treatment of choice for tense ascites. However, the mechanism of effective hypovolemia after paracentesis, the main complication associated with this procedure, remains unknown. In the current study, systemic hemodynamics was sequentially studied before and after total paracentesis in 46 patients with cirrhosis and tense ascites. The aim of the study was to assess the mechanism of effective hypovolemia after paracentesis.
METHODS: Plasma renin activity and aldosterone, mean arterial pressure, cardiac output (ECO-Doppler) and systemic vascular resistance were measured before, and 3 h, 6 h and 6 days after total paracentesis associated with plasma volume expansion.
RESULTS: Effective hypovolemia after paracentesis (defined as 50% increase in plasma renin activity up to a level over 4 ng x m(-1) x h(-1) at the 6th day after paracentesis) occurred in 20 cases [plasma renin activity increased from 8+/-17 to 19+/-2.7 ng x m(-1) x h(-1)]. In the remaining 26 cases no changes in plasma renin activity [8.5+/-2.4 vs. 8.7+/-2.2 ng x m(-1) x h(-1)] were observed. The amounts of ascitic fluid volume removed were similar. Effective hypovolemia after paracentesis was associated with a significant decrease in mean arterial pressure (89+/-2 vs. 81+/-3 mmHg) and systemic vascular resistance [1263+/-67 vs. 1014+/-80 dyn x s(-1) x cm(-5)] 6 days after treatment. In contrast, no significant changes in these parameters were observed in patients not developing this complication. In the whole group of patients a significant inverse relation was observed between changes in plasma renin activity and in systemic vascular resistance (r=0.74;p< 0.001).
CONCLUSIONS: These results indicate that effective hypovolemia after paracentesis in cirrhosis is predominantly due to an accentuation of the arteriolar vasodilation already present in these patients.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9566833     DOI: 10.1016/s0168-8278(98)80288-2

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  13 in total

1.  Predictors of large volume paracantesis induced circulatory dysfunction in patients with massive hepatic ascites.

Authors:  G Nasr; A Hassan; S Ahmed; A Serwah
Journal:  J Cardiovasc Dis Res       Date:  2010-07

2.  Beneficial and harmful effects of nonselective beta blockade on acute kidney injury in liver transplant candidates.

Authors:  Sang Gyune Kim; Joseph J Larson; Ji Sung Lee; Terry M Therneau; W Ray Kim
Journal:  Liver Transpl       Date:  2017-06       Impact factor: 5.799

Review 3.  Paracentesis-induced circulatory dysfunction: a primer for the interventional radiologist.

Authors:  Aaron J Lindsay; James Burton; Charles E Ray
Journal:  Semin Intervent Radiol       Date:  2014-09       Impact factor: 1.513

Review 4.  Albumin in chronic liver disease: structure, functions and therapeutic implications.

Authors:  Rosaria Spinella; Rohit Sawhney; Rajiv Jalan
Journal:  Hepatol Int       Date:  2015-09-29       Impact factor: 6.047

5.  Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study.

Authors:  R Moreau; T Asselah; B Condat; C de Kerguenec; F Pessione; B Bernard; T Poynard; M Binn; J D Grangé; D Valla; D Lebrec
Journal:  Gut       Date:  2002-01       Impact factor: 23.059

6.  Abdominal decompression plays a major role in early postparacentesis haemodynamic changes in cirrhotic patients with tense ascites.

Authors:  J Cabrera; L Falcón; E Gorriz; M D Pardo; R Granados; A Quinones; M Maynar
Journal:  Gut       Date:  2001-03       Impact factor: 23.059

7.  Albumin May Prevent the Morbidity of Paracentesis-Induced Circulatory Dysfunction in Cirrhosis and Refractory Ascites: A Pilot Study.

Authors:  Hiang Keat Tan; Paul Damien James; Florence Wong
Journal:  Dig Dis Sci       Date:  2016-04-05       Impact factor: 3.199

8.  Echocardiographic and Electrocardiographic Predictors of Adverse Outcomes in Spontaneous Bacterial Peritonitis.

Authors:  Mahek Shah; Soumya Patnaik; Obiora Maludum; Shantanu Patil; Toni Anne De Venecia; Vincent M Figueredo
Journal:  J Clin Exp Hepatol       Date:  2017-05-15

9.  Plasma expanders for people with cirrhosis and large ascites treated with abdominal paracentesis.

Authors:  Rosa G Simonetti; Giovanni Perricone; Dimitrinka Nikolova; Goran Bjelakovic; Christian Gluud
Journal:  Cochrane Database Syst Rev       Date:  2019-06-28

10.  What we know about paracentesis induced circulatory dysfunction?

Authors:  Jeong Han Kim
Journal:  Clin Mol Hepatol       Date:  2015-12-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.